Lung Cancer

Details

Serval ID
serval:BIB_D4D8D4B2D6B4
Type
A part of a book
Publication sub-type
Chapter: chapter ou part
Collection
Publications
Institution
Title
Lung Cancer
Title of the book
Side Effects in Systemic Cancer Therapy : Prevention and Treatment
Author(s)
Zimmerman S., Curioni Fontecedro A., Stahel R.A., Peters S.
Publisher
Springer
ISBN
978-0-85729-786-0
Publication state
Published
Issued date
2013
Editor
Dicato M.
Chapter
3
Pages
119-138
Language
english
Abstract
Lung cancer treatment strategy relies on an accurate staging of the disease and a careful evaluation of patient characteristics, including capability of undergoing and tolerating a defined treatment plan. Therefore, a solid knowledge on all intervention-related adverse events and drug toxicities is essential for a reliable decision-making process.
Most lung cancer patients are diagnosed at an advanced stage of the disease, correlated with a dismal prognosis. Systemic therapy is the mainstay, and drug selection still strongly relies on expected toxicity profile. This chapter first describes the drug standard options and their respective toxicities in this context. Side effects of more complex multimodality combined treatments of early non-small-cell lung cancer as well as small-cell lung cancer, usually involving use of the same cytotoxic agents jointly with surgery and radiotherapy, are discussed in the second part of this chapter.
Create date
23/02/2012 10:33
Last modification date
20/08/2019 16:54
Usage data